Category Archives: Pradaxa

Featured Stories

Another Metal-on-Metal Hip Replacement Lawsuit Filed in DePuy ASR Hip Implant Litigation

A vital food safety program was saved from budget cuts this week, enabling the country’s largest—although considered by experts to be far too small—produce-safety testing program to continue.

Read More

Canadian Study Confirms Actos Bladder Cancer Risk

A new study conducted by Canadian researchers has found that users of the type 2 diabetes drug, Actos (pioglitazone), may face a higher risk of developing bladder cancer than first thought. The study, published in the British Medical Journal, found that taking Actos for two years doubles the likelihood ...

Read More

Warning for Medtronic InterStim Neurostimulation Devices

Australian Health Agency Issues Warning for Battery Problem with Medtronic InterStim Neurostimulation Devices

Warning for Medtronic InterStim Neurostimulation DevicesTGA has issued a safety warning for InterStim and InterStim II neurostimulation devices, because of possible early depletion of the battery.

Read More

Fracking Releasing Hazardous Chemicals into Local Waterways

Fracking Releasing Hazardous Chemicals into Local Waterways

Study shows two hazardous chemicals—ammonium & iodide—are being released & spilled into Pennsylvania and W.Virginia waterways from fracking operations in Marcellus shale.

Read More

What Action Will the FDA Take on E-cigarettes?

What Action Will the FDA Take on E-cigarettes?

As health and quality concerns trouble the e-cigarette industry, experts and the public await the Food and Drug Administration (FDA)’s action to regulate the devices.

Read More

Louisiana Whistleblower Lawsuit Revived

Louisiana Whistleblower Lawsuit Revived

A state appeals court in Louisiana has ruled that a former employee of Rapides Parish Coliseum can proceed with a whistleblower lawsuit against the Coliseum Authority.

Read More

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

Conspiracy Claims in Talcum Powder Case Survive Motion to Dismiss

E. District of Missouri denied motion to dismiss conspiracy claims. Lawsuit alleges the defendants conspired to misrepresent true dangers with use of talcum powder.

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Birth Control Shot Depo-Provera may Increase HIV Risk

Birth Control Shot Depo-Provera may Increase HIV Risk, Study Suggests

A new study has linked the use of Depo-Provera (medroxyprogesterone acetate), an injectable type of birth control, to an increased risk of HIV infection.

Read More

Hip Replacement, Knee Implant Patients with Diabetes, Other Health Problems May Face Difficult Recoveries

Patients receiving hip replacement devices or knee implants may face a more complicated recovery if they are obese, or suffer from diabetes or other health woes. According to a new study published online in the journal Anesthesiology, at least 3% of all total hip or knee replacement patients will ...

Read More

Canadian Research Institutions Named Co-Defendants in Pradaxa Lawsuits in U.S.

pradaxa-canadian-research-defendants-in-trial

In an unusual situation, Canada’s McMaster University and Hamilton Health Sciences have been named co-defendants in lawsuits in U.S. federal court over the safety of the blood-thinning drug Pradaxa (dabigatran). The lawsuits allege that tainted data from mismanaged clinical trials … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

More than 2,000 Lawsuits Over Pradaxa Bleeding Risks, Boehringer Confirms

Pradaxa-Bleeding-Dangers

Boehringer Ingelheim, manufacturer of the blood-thinner Pradaxa (dabigatran), has confirmed that it faces more than 2,000 lawsuits in the United States alleging that the drug causes severe and fatal bleeding. The company’s confirmation came after the German newspaper Handelsblatt reported … Continue reading

Posted in Health Concerns, Legal News, Pharmaceuticals, Pradaxa |

Pradaxa Maker Sought to Revise, Suppress Controversial, Internal Research

pradaxa-maker-suppress-research

The maker of the controversial blood thinner, Pradaxa, was apparently worried that release of an internal study might impact sales. Boehringer Ingleheim employees allegedly pressured the study’s author to revise or suppress the study, according to recently unsealed legal documents, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Boehringer Fined $931,000 Over Lost Pradaxa Files

boehringer-fined-almost-one-million

Boehringer Ingelheim GmbH, which markets and manufactures Pradaxa, has been charged with a nearly $1 million fine, according to a recent ruling. The fine was levied for the drug maker’s withholding or failing to preserve files sought in Pradaxa litigation, … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study Finds Pradaxa Risky for Patients Implanted with Artificial Heart Valves

Pradaxa has been tied to more serious adverse reactions, according to a new study on Behringer Ingelheim’s blood thinner. The research revealed that when Pradaxa (dabigatran) is taken by patients with mechanical heart valves, there is an increase in risks … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Study: New Blood Thinners Associated with GI Bleed Risk

gi_bleeding_risks

Another study revealed issues related to new anti-coagulants, such as Pradaxa, including serious bleeds. The new study revealed that, based on a pooled analysis of 17 randomized controlled trials (RCTs) there was an increased risk of stomach bleeding in patients … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Pradaxa may Increase Viral Infection Risks, Severity, Study Shows

An new study found that the blood thinner, Pradaxa (dabigatran etexilate mesylate), may increase risks viral infections, as well as increasing the severity of these infections. University of North Carolina researchers discovered that the blood thinner blocks a critical component … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA: Blood Thinner, Pradaxa, Should Not Be Used by Patients with Mechanical Prosthetic Heart Valves

Blood thinner, Pradaxa (dabigatran etexilate mesylate), should not be used to prevent stroke or blood clots in patients implanted with mechanical heart valves. The U.S. Food and Drug Administration (FDA) has recently informed health care professionals and the public of … Continue reading

Posted in Pharmaceuticals, Pradaxa |

Was FDA’s Pradaxa® Analysis Flawed?

Despite a growing number of serious gastrointestinal bleed reports linked to Pradaxa®, the U.S. Food & Drug Administration (FDA) argues that the blood thinner, manufactured by Behringer Ingelheim, is safe when used as directed. Pradaxa® was approved two years ago … Continue reading

Posted in Pharmaceuticals, Pradaxa |

FDA backs previous stance on Pradaxa bleeding risks

Federal health officials have issued an update on its stance on the new blood thinner drug Pradaxa, indicating the risk of severe bleeding associated with the drug is no more significant than any other drugs available on the market for … Continue reading

Posted in Pharmaceuticals, Pradaxa | Tagged , |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.